Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy

[Image: see text] In an effort to develop potent, orally bioavailable compounds for the treatment of neoplastic diseases, we developed a class of dual VEGFR-2 kinase and tubulin inhibitors. Targeting the VEGFR receptor kinase and tubulin structure allows for inhibition of both tumor cells and tumor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chekler, Eugene L. Piatnitski, Kiselyov, Alexander S., Ouyang, Xiaohu, Chen, Xiaoling, Pattaropong, Vatee, Wang, Ying, Tuma, M. Carolina, Doody, Jacqueline F.
Formato: Artigo
Idioma:Inglês
Publicado: American Chemical Society 2010
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007844/
https://ncbi.nlm.nih.gov/pubmed/24900236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml1001568
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares